Company news

Nugen Medical Devices Inc (TSXV:NGMD) news

Nugen Medical Devices Inc news releases on 6ix. Latest, Sep 21, 2026: NuGen Announces Loan Agreement with Sol-Millennium Medical HK Limited

View Nugen Medical Devices Inc →

Press releases & updates

NuGen Announces Loan Agreement with Sol-Millennium Medical HK Limited

September 21, 2026

NuGen Announces Filing of Corrective Disclosure Pursuant to OSC Review

August 27, 2026

Canadian Investment Regulatory Organization Trading Halt - NGMD

August 6, 2026

NuGen Adds to Core Patent Portfolio for Future Needle-Free Platforms

July 27, 2026

NuGen Medical Devices Files Patent for Dual Spring Technology Enhancing Needle-Free Injection Performance

May 28, 2026

NuGen Files Patent for Ready-to-Fill COP/COC Needle-Free Injection Nozzle, Advancing Prefilled Nozzle Technology

March 25, 2026

NuGen Medical Devices Inc. Provides Update on Health Canada License

February 5, 2026

NuGen Medical Devices Inc. Announces CFO Transition

January 30, 2026

NuGen Medical Devices Provides 2025 Year End Update on R&D and Strategic Progress

January 16, 2026

NuGen Medical Devices Announces NHS Drug Tariff Approval for EziAutoJector(R) Product Line in the UK

September 26, 2025

NuGen Medical Devices Announces New Needle-Free Injection System Featuring Internal Cartridge Technology

August 21, 2025

InsuJet Distribution Expands Across France

July 7, 2025

NuGen Announces Release of 2024 Annual Financial Results

April 30, 2025

InsuJet Distribution Expands Across Canada

April 24, 2025

NuGen Announces the Appointment of Liang Lin as Chief Executive Officer

January 14, 2025

NuGen Announces Canada-Wide Launch of InsuJet

November 22, 2024

NuGen Announces Results of Special Meeting and Appointment of New Directors

November 14, 2024

NuGen Announces Strategic Partnership with EziAutoJector Limited

October 25, 2024

NuGen Announces Closing of Private Placement of $10 million Secured Convertible Debentures

September 20, 2024

NuGen Announces Release of Financial Results for Q2 2024 & Update on Proposed Private Placement

August 29, 2024

NuGen Announces Voting Results of Annual and Special Meeting

August 21, 2024

NuGen Announces Revised Terms of Proposed Private Placement of up to $10 Million Secured Convertible Debentures

August 15, 2024

NuGen Receives Order for Repeat Demand in Mexico

July 19, 2024

NuGen Announces Proposed Private Placement of up to $10 million Secured Convertible Debentures

July 10, 2024

NuGen Develops Pharmacist Training Packages for the Canadian Retail Pharmacy Market

July 9, 2024

NuGen Announces Completion of InsuJet(TM) Training with Sol-Millennium(TM) Brazil

July 1, 2024

NuGen Announces Repeat Order for Growing InsuJet(TM) Demand in Yemen

June 28, 2024

NuGen Announces Initial Purchase Order from Sol-Millennium(TM) for Pharmacy Launches in the Canadian and European Markets

June 21, 2024

NuGen Announces Release of Financial Results for Q1 2024 & Updates on Strong Commercial Momentum in Q2

May 30, 2024

NuGen Announces Debt Settlement and Amendments to Care4Pharma Share Purchase Agreement

April 15, 2024

NuGen Announces Completion of Product Training with Sol Millennium as European Markets Expand

January 30, 2024

NuGen Receives Two Additional Sales Orders for InsuJet(TM) and Expands Distribution into Argentina, Chile, Costa Rica and Peru

January 19, 2024

NuGen Medical Signs 5-year Distribution Agreement for InsuJet(TM) with Verrue Consulting Group in Belgium

December 19, 2023

NuGen Medical Signs 5-Year Distribution Agreement for InsuJet(TM) with Advance Medical Life Co.

December 14, 2023

NuGen Medical Devices names veteran medical executive Ian Heynen as Chief Executive Officer

December 11, 2023

InsuJet(TM) Registered as a Medical Device in Mexico

November 13, 2023

Diabetic Lifestyle Subscription Business Launched on Shopify as NuGen's B2C Business Vertical

November 7, 2023

MedTech Industry Leader Ian Heynen Commences CEO Role at NuGen

November 2, 2023

NuGen Medical Appoints Industry Leader Ian Heynen as CEO

October 12, 2023

Semaglutide - Ozempic(R) is Chemically Stable When Administered Using NuGen's Needle Free InsuJet(TM) Device

October 10, 2023

NuGen Medical Completes Delivery and First Sale of 500 InsuJet(TM) Devices and Consumables in Romania

September 20, 2023

NuGen Receives $1.3M Through Early Option and Warrant Exercise

September 11, 2023

NuGen Announces Participation at the 2023 Kinvestor Days Virtual Conference Tech Day

September 5, 2023

NuGen Provides Corporate Update

August 4, 2023

RETRANSMISSION: NuGen Signs $204M Distribution Agreement With Global Leader in the Diabetic Industry

July 26, 2023

NuGen Signs $204M Distribution Agreement With Global Leader in the Diabetic Industry

July 24, 2023

NuGen Ships First InsuJet(TM) Devices and Consumables to the UK and Attends Diabetes Professional Care Conference

June 30, 2023

NuGen Medical Devices Receives First Bulk-Order Payment and Will Ship 500 InsuJets(TM) to Mexico

June 23, 2023

NuGen Medical Sells 800 InsuJet(TM) Devices and Consumables in Yemen

June 16, 2023

Porter Media Engaged by NuGen Medical for Online Marketing of InsuJet(TM)

June 14, 2023

Older →